Nuvectis Pharma, Inc. (NVCT)
23.62
-1.58
(-6.25%)
USD |
NASDAQ |
Aug 28, 16:00
23.62
0.00 (0.00%)
After-Hours: 17:12
Nuvectis Pharma EPS Diluted (TTM) : -1.278 for June 30, 2026
EPS Diluted (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical EPS Diluted (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | -1.278 |
| March 31, 2026 | -1.275 |
| December 31, 2025 | -1.284 |
| September 30, 2025 | -1.320 |
| June 30, 2025 | -1.125 |
| March 31, 2025 | -1.091 |
| December 31, 2024 | -1.075 |
| September 30, 2024 | -1.135 |
| June 30, 2024 | -1.259 |
| March 31, 2024 | -1.373 |
| December 31, 2023 | -1.396 |
| Date | Value |
|---|---|
| September 30, 2023 | -1.474 |
| June 30, 2023 | -1.527 |
| March 31, 2023 | -1.431 |
| December 31, 2022 | -1.478 |
| September 30, 2022 | -1.198 |
| June 30, 2022 | -1.147 |
| March 31, 2022 | -1.333 |
| December 31, 2021 | -1.014 |
| September 30, 2021 | -0.8357 |
| June 30, 2021 | -0.4687 |
| March 31, 2021 | -0.0018 |
EPS Diluted (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (TTM) Benchmarks
| Decoy Therapeutics, Inc. | -47.29 |
| Unicycive Therapeutics, Inc. | -1.596 |
| ACADIA Pharmaceuticals, Inc. | 2.220 |
| Alnylam Pharmaceuticals, Inc. | 5.923 |
| Anika Therapeutics, Inc. | -0.2741 |